Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics

revised

  • 94(4):558
AMERICAN ACADEMY OF PEDIATRICS

Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation

; Subcommittee on Hyperbilirubinemia
Pediatrics July 2004, 114 (1) 297-316; DOI: https://doi.org/10.1542/peds.114.1.297
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 114, Issue 1
1 Jul 2004
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
Pediatrics Jul 2004, 114 (1) 297-316; DOI: 10.1542/peds.114.1.297

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
Pediatrics Jul 2004, 114 (1) 297-316; DOI: 10.1542/peds.114.1.297
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Abstract
    • BACKGROUND
    • DEFINITION OF RECOMMENDATIONS
    • BILIRUBIN ENCEPHALOPATHY AND KERNICTERUS
    • FOCUS OF GUIDELINE
    • PRIMARY PREVENTION
    • SECONDARY PREVENTION
    • TREATMENT
    • IMPLEMENTATION STRATEGIES
    • FUTURE RESEARCH
    • CONCLUSIONS
    • APPENDIX 1: Additional Notes
    • APPENDIX 2: Phototherapy
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • Comments

Related Articles

  • ERRATUM
  • PubMed
  • Google Scholar

Cited By...

  • Systematic review of global clinical practice guidelines for neonatal hyperbilirubinemia
  • Small-Area Variation in the Care of Low-Risk Neonates in Massachusetts and Texas
  • Neonatal Indirect Hyperbilirubinemia
  • Is it safe to use visible blue light-emitting diode phototherapy for neonatal jaundice in infants who are also treated with amiodarone?
  • Variation in Care and Clinical Outcomes Among Infants Hospitalized With Hyperbilirubinemia
  • Case 1: Rapidly Rising Bilirubin Level in a 3-day-old Term Infant
  • Determinants of neonatal jaundice among neonates admitted to five referral hospitals in Amhara region, Northern Ethiopia: an unmatched case-control study
  • Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening
  • Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions
  • Supporting Breastfeeding in Infants Hospitalized for Jaundice
  • Extreme neonatal hyperbilirubinaemia in refugee and migrant populations: retrospective cohort
  • Pathogenesis and Management of Indirect Hyperbilirubinemia in Preterm Neonates Less Than 35 Weeks: Moving Toward a Standardized Approach
  • Providing Care for Infants Born at Home
  • Evidence-Based Updates on the First Week of Exclusive Breastfeeding Among Infants >=35 Weeks
  • Prevalence of and mothers knowledge, attitude and practice towards glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice: a cross-sectional study
  • Prediction of Rebound Hyperbilirubinemia
  • Legal Briefs: Multiple Missteps and System Failures Cause Kernicterus in 2 Infants
  • Case 1: Severe Jaundice in a 2-day-old Term Neonate
  • Potential protective effects of bilirubin following the treatment of neonatal hypoxic-ischemic encephalopathy with hypothermia therapy
  • A Novel Icterometer for Hyperbilirubinemia Screening in Low-Resource Settings
  • Congenital Syphilis: A Challenging Case for NICU Clinicians
  • Screening and treatment to reduce severe hyperbilirubinaemia in infants in primary care (STARSHIP): a factorial stepped-wedge cluster randomised controlled trial protocol
  • Phototherapy for Neonatal Unconjugated Hyperbilirubinemia: Examining Outcomes by Level of Care
  • Exposure to Phototherapy and Childhood Seizure Risk
  • Wireless, battery-free, flexible, miniaturized dosimeters monitor exposure to solar radiation and to light for phototherapy
  • The Snowball Effect of Low-Value Care
  • How to evaluate diagnosis and management of biliary atresia in the era of liver Transplantation in China
  • Adherence to AAP Healthy Newborn Discharge Criteria in a Tertiary Care Childrens Hospital
  • Hyperbilirubinemia, Phototherapy, and Childhood Asthma
  • Outcomes of neonatal jaundice in Taiwan
  • Childhood Seizures After Phototherapy
  • Phototherapy and Seizures: Should We Change Practice?
  • Beyond "Asian": Specific East and Southeast Asian Races or Ethnicities Associated With Jaundice Readmission
  • Neonatal Jaundice: Improved Quality and Cost Savings After Implementation of a Standard Pathway
  • Neonatal Hyperbilirubinemia and Chronic Auditory Toxicity
  • Burden of severe neonatal jaundice: a systematic review and meta-analysis
  • Jaundice: Newborn to Age 2 Months
  • Chronic Auditory Toxicity in Late Preterm and Term Infants With Significant Hyperbilirubinemia
  • Use of a Smartphone App to Assess Neonatal Jaundice
  • Re: Changs Score Is Only Helpful Within the First 4 to 5 Days of Life
  • Current Scope of Practice for Newborn Care in Non-Intensive Hospital Settings
  • A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy
  • We Can Teach How to Bend the Cost Curve: Lessons in Pediatric High-Value Health Care
  • Can I Stop Phototherapy for This Baby?
  • Update on Pediatric Overuse
  • Transcutaneous Bilirubinometry in Jaundiced Neonates: A Randomized Controlled Trial
  • Hereditary Spherocytosis
  • Phototherapy and Risk of Type 1 Diabetes
  • The Bilirubin Binding Panel: A Henderson-Hasselbalch Approach to Neonatal Hyperbilirubinemia
  • Differences Between Transcutaneous and Serum Bilirubin Measurements in Black African Neonates
  • Battery-free, stretchable optoelectronic systems for wireless optical characterization of the skin
  • Evaluating Nursery Phototherapy Use and Discharge Practices After the Creation of a Weekend Newborn Clinic
  • Retrospective Cohort Study of Phototherapy and Childhood Cancer in Northern California
  • Neonatal Phototherapy and Infantile Cancer
  • Utility of Decision Rules for Transcutaneous Bilirubin Measurements
  • When Intensive Care Is Too Intense: Variations in Standard Practices Across Hospital Acuity Levels
  • Benefits of Delayed Cord Clamping in Red Blood Cell Alloimmunization
  • The Blockade of NF-{kappa}B Activation by a Specific Inhibitory Peptide Has a Strong Neuroprotective Role in a Sprague-Dawley Rat Kernicterus Model
  • Predicting Nonhemolytic Neonatal Hyperbilirubinemia
  • Topics in Neonatal Informatics: Essential Functionalities of the Neonatal Electronic Health Record
  • Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn
  • A Model for Predicting Significant Hyperbilirubinemia in Neonates From China
  • Risk of Sensorineural Hearing Loss and Bilirubin Exchange Transfusion Thresholds
  • How to use: the direct antiglobulin test in newborns
  • A Pediatrician's Practical Guide to Diagnosing and Treating Hereditary Spherocytosis in Neonates
  • Medical Evaluation of Abandoned Infants Less Than 61 Days of Age
  • Early Weight Loss Nomograms for Formula Fed Newborns
  • Hospital Stay for Healthy Term Newborn Infants
  • Google Scholar

More in this TOC Section

  • Exposure to Nontraditional Pets at Home and to Animals in Public Settings: Risks to Children
  • Medical Emergencies Occurring at School
  • Disaster Planning for Schools
Show more AMERICAN ACADEMY OF PEDIATRICS

Similar Articles

Subjects

  • Nephrology
    • Nephrology
  • AAP Policy Collections by Authoring Entities
    • Steering Committee on Quality Improvement and Management
    • Subcommittee on Hyperbilirubinemia
  • Current Policy
  • Fetus/Newborn Infant
    • Fetus/Newborn Infant
    • Hyperbilirubinemia
  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics